INSY Archives - Page 3 of 3 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: TEUM Update & More

Pareteum Corp. TEUM

The last time we mentioned TEUM was December 8th, shortly after which time the stock was trading for as little as .661. At the time the company had no involvement in the trendy cryptocurrency space.

Flash forward to this week, and an announcement that the company is adding blockchain capability for cryptocurrency support on its global cloud billing platform has the stock soaring to new highs.

TEUM hit 3.15 yesterday, which marks an increase of 377% in less than three weeks’ time. Volume for the day was on the order of roughly five times the monthly average.

Bitcoin itself has been making a nice rebound after the pullback which followed its big run to nearly $20K, and there is no reason to suspect that the push toward blockchain related technologies, both cryptocurrency and otherwise, is just a passing fad.

INSYS Therapeutics, Inc. INSY – Options Recap

We made our interest in the INSY 01/19 $8 & $9 Calls known yesterday morning, and it barely took any time at all for our ideas to come to fruition.

As we were mentioning yesterday, the company recently initiated Phase II trials of its synthetic Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy, and the FDA granted Fast Track status to the ‘drug’ for the treatment of a rare genetic disorder (Prader-Willi).

This news allowed for some very nice moves in our designated contracts. The $8 Calls ran from .35-1.00 for a gain of 186%, while the $9’s traded up from .20-.55, trending up 175% on the day.

Ampio Pharmaceuticals, Inc. AMPE

We also want to swing back to remind our readers of last week’s alert on AMPE. We tagged this play seven days ago (four trading days), and saw it trading for as little as 2.57. As of yesterday’s high of 3.55, the stock had thus far risen by 38%

The stock’s peak PPS represented a new annual high, so we’ll be interested to see how the stock performs in blue skies.

Extended Watchlist:
OTIV, FH, NETE, LFIN, GROW, IDXG, WATT, ATNM

Blue Horseshoe Stocks: Kicking Off the Short Week

INSYS Therapeutics, Inc. INSY

This morning we kick off the holiday shortened week, during a time of year that typically sees subdued activity for the markets as a whole, as people spend time with their families, and stay busy with holiday festivities.

We still strive to identify possible opportunities even in this environment, and the first thing to hit our scanner this morning was INSY. INSYS Therapeutics recently initiated Phase II trials of its synthetic Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy.

The FDA, we’re learning today, has also granted Fast Track status to INSY for the ‘drug’ for the treatment of Prader-Willi syndrome, a rare and complex genetic disorder. (View PR)

The stock registered its 52-week lows at the beginning of last month, and has been in a general uptrend since, but we’ll be looking for further bullish activity on the heels of this FDA news, both on the stock chart, and in the options chain as a secondary idea. For that, we’ll look to the INSY 01/19 $8 & $9 Calls for opportunities.

DelMar Pharmaceuticals, Inc. DMPI

Speaking of FDA Fast Track designations, we’re looking to DMPI this morning as well, which was granted the status by the FDA for its lead-product cancer treatment, VAL-083.

The chart itself was already set up as a possible bottom play, and despite gapping up considerably on this morning’s news, there is still room to the upside, including a sizable gap that’s been left on the chart since this past spring, the eventual filling of which would spell gains of more than 100% from the current PPS.

Extended Watchlist:
KLXI, EXXI, AEZS, SRAX, IMUC, NETE

Blue Horseshoe Stocks: Options Updates, Fresh Ideas

Best Buy Co. Inc. BBY – Options Update

We signaled a range of BBY options yesterday after noticing a hefty earnings beat that was driving the stock to gap up significantly in the premarket.

The bullish trend continued throughout the day, as BBY stock traded in a range from 37.66-39.36. That facilitated some big-time single-session gain opportunities for our specified targets, which were the BBY Weekly 36.50-39 Calls.

It wouldn’t have mattered which set of contracts in the highlighted range were selected, as every single one put up a standout performance, yielding the following potential gains:

$36.50 Calls – Range: 1.43-2.53 – Max Gain: 77%
$37 Calls – Range: 1.10-2.32 – Max Gain: 111%
$37.50 Calls – Range: .77-2.78 – Max Gain: 261%
$38 Calls – Range: .53-1.52 – Max Gain: 187%
$38.50 Calls – Range: .32-2.23 – Max Gain: 597%
$39 Calls – Range: .20-.80 – Max Gain: 300%

For us to remain interested in continuing to track these ideas, we’ll need to see BBY maintain support above the 37.50-mark on any pullbacks.

World Poker Fund Holdings, Inc. WPFH

We also tagged WPFH in yesterday morning’s premarket report, and while it didn’t produce a monster move like the aforementioned options plays, it did manage to make a notable increase on the day.

From a low of .53, the stock traded up to .70, marking an intraday move of 32% We’re going to want to continue to keep an eye on this play as it continues to make headway off of its recent bottom.

Dominovas Energy Corp. DNRG

Speaking of stocks where we’ve caught a bottom, we want to comment quickly on the progress of DNRG, a stock which has appeared in our reports on multiple occasions.

Our most recent mention of this play was earlier this month, following which time we observed a low of .0015. Yesterday the stock attained a new high of .0055, representing an increase of 267% in just a few weeks’ time.

Vista Outdoor, Inc. VSTO – Fresh Options Idea

VSTO is an interesting candidate for a forthcoming recovery, and we want to be waiting in the wings for that possibility. Despite a recent earnings miss a few weeks back, coupled with an analyst downgrade, the company’s long-term figures show a slow but steady growth in key areas.

The chart itself is egregiously oversold, with this most recent selloff lasting through the past ten sessions. Whenever we see a stock with solid fundamentals getting abused like this, our bottom-feeding alarms begin to sound.

We’re going to watch this play closely in the weeks ahead, along with a pair of extended-term contracts in its options chain, specifically, the VSTO 10/21 $35 and $40 Calls. A recovery of any significance should produce some interesting activity in those plays.

Extended Watchlist:
INSY, RADA, CBR, NMBL, BSRC, BTHE

Blue Horseshoe Stocks: APRE Recap, Other Updates & More

Aperture Health, Inc. APRE

When we took a glance at the APRE chart in the premarket yesterday morning, we felt confident that there was a possibility of a continued uptrend carried over from Friday’s big move. Our feelings weren’t misplaced, as the stock recorded another nice intraday run beginning right at the opening bell.

From its starting price of .027 APRE broke out to a high of .0428, which registered as a 59% upswing. We then saw a consolidation into the close, exhibiting the type of volatility we’d mentioned in our report, but notably held support above the .03-mark.

We’re going to look for APRE to continue to build higher base levels of support moving forward. We can imagine a play with such technical characteristics providing us further opportunities in sessions ahead, so we’ll want to keep it on close watch.

If you didn’t catch our full report on APRE yesterday, you can find it here >>View Report

Updates on Recent Ideas

We get so caught up with our seemingly innumerable interests at times, that we sometimes find ourselves having to backtrack a bit to provide updates on past ideas. Such is the case with the following stocks:

PCS Edventures!.com, Inc. PCSV, which we tabbed for longer-term watch two months ago to the day, ended up making a beautiful upswing of multi-bag proportions. Subsequent to our alert, we witnessed it trading in a range from .025-.14, a 460% move to the upside.

Skyline Medical, Inc. SKLN is a play that we zeroed in on late last month, and it too yielded a sizable move recently. The stock ran from .17-.29 for a comparatively modest but still very solid 71% spike.

Eyes on the Cannabis Sector

Our regular readers are certainly familiar with our repeated tracking of marijuana-related stocks, a pool from which we’ve pulled a great many big-time gainers in the past. We began drawing attention back to the sector in our reports early this spring, and it has really paid off.

GreenGro Technologies, Inc. GRNH – We’ve come back to this one time and time again over a period of years, but began tracking it more heavily beginning in late February. Since then, the general trend has been in a northerly direction, and over the past month or so, things have really begun to kick in high gear. In that span, we’ve seen GRNH run from a low of .0171 to an amazing ten-cent high yesterday. That’s a 485% swing! The stock has gapped up even further today, as high as .12 so far in the premarket, so it’s definitely occupying a portion of our attention this morning.

Terra Tech Corp. TRTC – We began re-alerting TRTC around the same period in late March at which time we observed a low of .2162 , and our most recent reminder came on April 5th. For this play as well, it has been mostly big moves to the upside since then. Yesterday the stock reached .7455, marking a 245% swing over our observed low.

Other big pot-plays that we dialed up near the end of March included Marijuana Company of America, Inc. MCOA and CannLabs, Inc. CANL. We’ve seen multi-bag moves from them as well, culminating in impressive new highs yesterday. MCOA ran from our observed low of .005 to a new high of .012, a gain of 140% while CANL made a move from .167-.449 for a solid 169% rip.

It’s become increasingly apparent over recent weeks that the cannabis industry heat-up we had anticipated is in full-swing. We’re going to need to stay aware and continue to monitor the entire sector, including stocks such as CANN, and CBDS as spring progresses.

Extended Watchlist:
EPXY, SVBL, INSY, GWPH